These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27530753)

  • 1. Comment on: Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.
    Imkamp F; Keller PM; Böttger EC
    J Antimicrob Chemother; 2016 Dec; 71(12):3624. PubMed ID: 27530753
    [No Abstract]   [Full Text] [Related]  

  • 2. Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system-authors' response.
    Hoffmann H; Borroni E; Schena E; Nedialkova L; Hofmann-Thiel S; Cirillo D
    J Antimicrob Chemother; 2016 Dec; 71(12):3625. PubMed ID: 27621178
    [No Abstract]   [Full Text] [Related]  

  • 3. Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.
    Schena E; Nedialkova L; Borroni E; Battaglia S; Cabibbe AM; Niemann S; Utpatel C; Merker M; Trovato A; Hofmann-Thiel S; Hoffmann H; Cirillo DM
    J Antimicrob Chemother; 2016 Jun; 71(6):1532-9. PubMed ID: 27076101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothionamide susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTECMGIT 960 system.
    Tan Y; Su B; Zheng H; Wang Y; Pang Y
    Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):779-782. PubMed ID: 28000029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of critical concentrations of moxifloxacin and gatifloxacin for drug susceptibility testing of Mycobacterium tuberculosis in the BACTEC MGIT 960 system.
    Isaeva Y; Bukatina A; Krylova L; Nosova E; Makarova M; Moroz A
    J Antimicrob Chemother; 2013 Oct; 68(10):2274-81. PubMed ID: 23788475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis.
    Montoro E; Lemus D; Echemendia M; Martin A; Portaels F; Palomino JC
    J Antimicrob Chemother; 2005 Apr; 55(4):500-5. PubMed ID: 15731200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assay.
    Campanerut PA; Ghiraldi LD; Spositto FL; Sato DN; Leite CQ; Hirata MH; Hirata RD; Cardoso RF
    J Antimicrob Chemother; 2011 May; 66(5):1044-6. PubMed ID: 21393185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
    Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM
    J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: phenotypic and genotypic methods.
    Miyata M; Pavan FR; Sato DN; Marino LB; Hirata MH; Cardoso RF; de Melo FA; Zanelli CF; Leite CQ
    Biomed Pharmacother; 2011 Sep; 65(6):456-9. PubMed ID: 21880463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs.
    Gallo JF; Pinhata JMW; Saraceni CP; de Oliveira RS
    J Microbiol Methods; 2017 Aug; 139():168-171. PubMed ID: 28601653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility.
    Banfi E; Scialino G; Monti-Bragadin C
    J Antimicrob Chemother; 2003 Nov; 52(5):796-800. PubMed ID: 14519676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimisation of the microplate resazurin assay for screening and bioassay-guided fractionation of phytochemical extracts against Mycobacterium tuberculosis.
    O'Neill TE; Li H; Colquhoun CD; Johnson JA; Webster D; Gray CA
    Phytochem Anal; 2014; 25(5):461-7. PubMed ID: 24733665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK; Tyagi JS
    J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar.
    Rivoire N; Ravololonandriana P; Rasolonavalona T; Martin A; Portaels F; Ramarokoto H; Rasolofo Razanamparany V
    Int J Tuberc Lung Dis; 2007 Jun; 11(6):683-8. PubMed ID: 17519102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method.
    Bastian I; Rigouts L; Palomino JC; Portaels F
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1934-6. PubMed ID: 11353658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives.
    Patel KN; Telvekar VN
    Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
    Pina RZ; Caleffi-Ferracioli KR; Campanerut-Sá PA; Ghiraldi-Lopez LD; Pavan FR; Siqueira VL; Scodro RB; Cardoso RF
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1535-1538. PubMed ID: 27776597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs.
    Martin A; Morcillo N; Lemus D; Montoro E; Telles MA; Simboli N; Pontino M; Porras T; León C; Velasco M; Chacon L; Barrera L; Ritacco V; Portaels F; Palomino JC
    Int J Tuberc Lung Dis; 2005 Aug; 9(8):901-6. PubMed ID: 16104638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between susceptibility of Mycobacterium tuberculosis by microtiter plate alamar blue assay and clinical outcomes.
    Sungkanuparph S; Pracharktam R; Thakkinstian A; Buabut B; Kiatatchasai W
    J Med Assoc Thai; 2002 Jul; 85(7):820-4. PubMed ID: 12296415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis.
    Dixit P; Singh U; Sharma P; Jain A
    J Microbiol Methods; 2012 Jan; 88(1):122-6. PubMed ID: 22133919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.